Duke University Fuqua School of Business News
As healthcare management becomes ever more important, more doctors are enrolling in business school. BusinessBecause talked to six physicians who did an MBA to find out why
September 28, 2021 14:25
5 MBA Admissions Trends For 2022 | How Competitive Is Your Application?
Applying for business school this admissions cycle? Here are the key MBA admissions trends for 2022 and how they might affect your application
September 27, 2021 10:00
Duke Fuqua School of Business MBA Jobs & Salary Review
Which companies hire MBAs from Duke University’s Fuqua School of Business? What do Duke Fuqua MBAs earn? Find out in our Fuqua MBA Jobs & Salary Review
August 19, 2021 10:00
MIT Sloan Is World’s Most Expensive MBA Program in 2021
MIT Sloan is the world's most expensive top MBA program, according to the BusinessBecause Cost of MBA Report 2021, which takes into account tuition fees, living expenses, and healthcare costs
July 20, 2021 12:09
2
From the leadership skills that will help you stand out to tips on asking for a job promotion, find out what you need to do to get promoted at work
June 28, 2021 10:00
Where Do McKinsey, Bain, BCG Hire The Most MBAs?
The MBB consulting firms—McKinsey, Bain, and BCG—are major recruiters of MBA grads. But which business schools do they recruit from the most?
June 16, 2021 17:22
10 Best MBAs For Investment Banking
What are the best MBA programs for a careers in investment banking? Firms like Morgan Stanley and Goldman Sachs love hiring MBAs from these top business schools
June 16, 2021 16:49
You’ve Got An MBA Rejection Letter. Should You Reapply?
You’ve got your MBA rejection letter, but there’s still a chance of getting into your dream MBA. Find out how to be a strong reapplicant and increase your chance of admission to the same school
June 2, 2021 10:00
4
How America’s Business Schools Are Ramping Up MBA Diversity
US business schools are taking steps to boost MBA diversity and reach out to Black and Latinx candidates
May 24, 2021 15:40
From Startup To $67 Billion Company | 3 Lessons From Moderna's Vaccine Success
Pre-pandemic, biotech company Moderna had never launched a product. Now the company’s vaccine has propelled its market capitalization to $67 billion. Here are three lessons from Moderna’s success
April 21, 2021 16:00